Novavax Files COVID-19 Vaccine Candidate With UK Regulator

Product Still Under Rolling Review In EU

The company says it expects a “positive decision” on the first approval application for a protein-based coronavirus vaccine in the UK. If approved, NVX-CoV2373 would become the fifth COVID-19 jab to reach the market there.

Close-up view of searching information on COVID 19 vaccine on the internet
A fifth COVID-19 vaccine could soon be approved by the MHRA • Source: Alamy

Novavax, Inc. has completed its rolling regulatory submission to the UK regulator, the MHRA, for the approval of its COVID-19 vaccine NVX-CoV2373. If approved, it will join the four other coronavirus vaccines already on the market.

The filing is noteworthy for two reasons, one being that it is the first for a protein-based coronavirus vaccine in...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography